A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127), which fundamentally misconstrues the role of pharmacy benefit companies, unfairly proposes to take away employers’
Misguided Legislation Targets Pharmacy Benefits That Save Employers and Patients an Average of $1,000 Per Person Each Year and Undermines Market Forces in Health Care In case you missed it, leading economic experts and competition watchdogs have overwhelmingly expressed concern
(Washington, D.C.) — The Pharmaceutical Supply and Payment Chain Coalition issued the following statement in response to the Administration’s 100-day review of the actions needed to address vulnerabilities in our nation’s pharmaceutical supply chain and what measures need to be taken in order
Court Ruling Finds that ERISA Preempts State PBM Law COURT REJECTS BID TO PREEMPT ERISA…In a unanimous decision, the U.S. Court of Appeals for the Tenth Circuit in PCMA v. Mulready court sustained PCMA’s challenge to four provisions in
(Washington, D.C.) — Today, representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter brand and generic manufacturers; wholesalers; retail, specialty, and managed care, pharmacies; health insurance providers and other payers; pharmacists in hospitals and health systems; and
JC Scott President & Chief Executive Officer JC Scott is the President and CEO of the Pharmaceutical Care Management Association (PCMA), the national association representing America’s pharmacy benefit managers, or PBMs. PBMs administer prescription drug plans for more than 275
The Honorable Michael R. Pence Vice President of the United States Chair of the White House Coronavirus Task Force The White House 1600 Pennsylvania Avenue, N.W. Washington, DC 20500 Dear Mr. Vice President: As our nation works tirelessly to address
In case you missed it, a new article in The Atlantic explains how big drug companies commonly use an anti-competitive tactic, “pay-for-delay,” to prevent more affordable options from entering the marketplace.
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing new staff additions to the Federal Affairs, State Affairs, Strategic Communications, and Industry Relations departments. “I want to welcome Jocelyn Wiles, Heather Cascone, Mike Baldyga, and Kayla Firriolo to PCMA’s
Agnita Kote Chief Financial Officer Agnita Kote is the Chief Financial Officer for PCMA. She provides strategic financial planning and management of PCMA’s financial affairs. Agnita has more than a decade of finance and accounting experience. Prior to joining PCMA, she
©2024 PCMA. All Rights Reserved.
